A report from China’s State Council Information Office shows that Chinese-made medicines and medical devices are gaining a stronger foothold in global health markets.

• Export Growth: In the first 11 months of 2025, China’s medicine exports reached approximately US$100.899 billion, with strong contributions from active pharmaceutical ingredients and medical devices.
• Out-Licensing Deals: Chinese pharmaceutical companies signed about US$135.7 billion worth of cross-border out-licensing agreements in 2025, significantly up from 2024.
• Market Access Platforms: Platforms such as the China-ASEAN Regional Medical Products Trading Platform are helping reduce trade barriers and support engagement with regional partners.

This summary is based on an article from the State Council Information Office of China.